NIK-SMI1 |
Inhibitor of MAP3K14
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAP3K14 |
|
|
Inhibitor
150-400 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
RelB 70 nM, RelA no inhibition, KHS1 > 50% in a 228 panel of kinases tested at 0.100 μM
In Cell Selectivity Assessment
Selectivity Assessment Description:
Outside target family - Indirect: no inhibition of nuclear translocation of RelA
Potency Cellular
In Vitro
MAP3K14
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.8b00678
In Vivo Validations
Rat, Mouse, Dog, Monkey
Dose: 5 mg/Kg, Reviewer suggests higher than 100-200 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
84.9/90.1/95.3 % (H/R/M)
Systemic clearance:
6.5/21/53/16/19 mL/min/Kg (H/R/M/D/C)
DOI Reference: 10.1021/acs.jmedchem.8b00678
Chemical Information
| Molecular Formula | C20H19N3O4 |
| SMILEs | COc1cc(C(N)=O)nc(-c2cccc(C#C[C@]3(O)CCN(C)C3=O)c2)c1 |
| InChI | InChI=1S/C20H19N3O4/c1-23-9-8-20(26,19(23)25)7-6-13-4-3-5-14(10-13)16-11-15(27-2)12-17(22-16)18(21)24/h3-5,10-12,26H,8-9H2,1-2H3,(H2,21,24)/t20-/m0/s1 |
| Molecular weight | 365.14 Da |
| AlogP | 0.8007999999999996 |
| HBond acceptors | 7 |
| HBond donors | 3 |
| Atoms | 46 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.